Methotrexate 25 mg/ml solution for injection, pre-filled syringe United Kingdom - English - myHealthbox

methotrexate 25 mg/ml solution for injection, pre-filled syringe

hameln pharmaceuticals ltd - methotrexate - solution for injection in pre-filled syringe - 25 mg/ml - antineoplastic and immunomodulating agents, antimetabolites, folic acid analogues - active rheumatoid arthritis in adult patients where treatment with disease modifying antirheumatic drugs (dmard) is indicated; polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to non-steroidal anti-inflammatory drugs (nsaids) has been inadequate; severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy, puva, and retinoids, and severe psoriatic arthritis

OXYCODONE-HAMELN oxycodone hydrochloride 50 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 50 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: citric acid monohydrate; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide; sodium chloride - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 10 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 10 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 20 mg/2 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 20 mg/2 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

ALFENTANIL-HAMELN alfentanil (as hydrochloride) 5 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

alfentanil-hameln alfentanil (as hydrochloride) 5 mg/10 ml solution for injection ampoule

hameln pharma pty ltd - alfentanil hydrochloride, quantity: 5.438 mg (equivalent: alfentanil, qty 5 mg) - injection, solution - excipient ingredients: sodium chloride; dilute hydrochloric acid; water for injections - alfentanil-hameln is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil-hameln is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil-hameln is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil-hameln or by adapting the infusion rate.